Search by Drug Name or NDC

    NDC 00075-0621-60 Lovenox 60 mg/.6mL Details

    Lovenox 60 mg/.6mL

    Lovenox is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is ENOXAPARIN SODIUM.

    Product Information

    NDC 00075-0621
    Product ID 0075-0621_3aafdd4d-7816-40f2-a675-af0e97fa0552
    Associated GPIs 8310102010E530
    GCN Sequence Number 027993
    GCN Sequence Number Description enoxaparin sodium SYRINGE 60MG/0.6ML SUBCUT
    HIC3 M9K
    HIC3 Description HEPARIN AND RELATED PREPARATIONS
    GCN 62771
    HICL Sequence Number 007878
    HICL Sequence Number Description ENOXAPARIN SODIUM
    Brand/Generic Brand
    Proprietary Name Lovenox
    Proprietary Name Suffix n/a
    Non-Proprietary Name enoxaparin sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 60
    Active Ingredient Units mg/.6mL
    Substance Name ENOXAPARIN SODIUM
    Labeler Name Sanofi-Aventis U.S. LLC
    Pharmaceutical Class Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020164
    Listing Certified Through 2024-12-31

    Package

    NDC 00075-0621-60 (00075062160)

    NDC Package Code 0075-0621-60
    Billing NDC 00075062160
    Package 10 CELLO PACK in 1 CARTON (0075-0621-60) / 1 SYRINGE in 1 CELLO PACK (0075-0621-01) / .6 mL in 1 SYRINGE
    Marketing Start Date 1993-03-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5017a927-2a24-4f27-89f9-27c805bf7d59 Details

    Revised: 1/2022